V

Veracyte
D

VCYT

27.145
USD
-0.25
(-0.89%)
مغلق
حجم التداول
21,223
الربح لكل سهم
1
العائد الربحي
-
P/E
65
حجم السوق
2,125,850,116
أصول ذات صلة
A
ADPT
0.09500
(1.08%)
8.92500 USD
BMRN
BMRN
-0.490
(-0.85%)
57.500 USD
DXCM
DXCM
-0.240
(-0.28%)
84.540 USD
F
FATE
-0.02000
(-1.68%)
1.17000 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
R
RGEN
-2.440
(-2.03%)
118.050 USD
T
TDOC
-0.09000
(-1.31%)
6.80000 USD
VEEV
VEEV
-2.506
(-1.06%)
232.990 USD
المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.